NP Life Sciences Health Industry Group Inc. (ACAT) stock
ACATOTCServices-Educational ServicesFiscal year ends December 31
Financials through Q4 FY2023, quarter ended Dec 31, 2023Last filing: 10-K on Apr 16, 2024
$10.00+0.00 (0.00%)
Close on Oct 19, 2026Market cap $429.60MP/E –Yield –
NP Life Sciences Health Industry operating margin
Operating margin is operating income as a percentage of revenue.
NP Life Sciences Health Industry's operating margin for the twelve months ending Dec 31, 2023 was -0.4%. For fiscal 2023 it was -0.4%, against -18.5% the year before. The highest annual figure on record is -0.4% in fiscal 2023.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -0.4% | +18.1 |
| FY2022 | Dec 31, 2022 | -18.5% | +169.2 |
| FY2021 | Dec 31, 2021 | -187.7% | +686.2 |
| FY2020 | Dec 31, 2020 | -873.9% | −620.8 |
| FY2019 | Dec 31, 2019 | -253.2% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2023 | Dec 31, 2023 | -358.4% | −394.4 |
| Q3 FY2023 | Sep 30, 2023 | -213.8% | −200.5 |
| Q2 FY2023 | Jun 30, 2023 | 66.7% | +59.5 |
| Q1 FY2023 | Mar 31, 2023 | 4.1% | +205.0 |
| Q4 FY2022 | Dec 31, 2022 | 36.1% | +56.3 |
| Q3 FY2022 | Sep 30, 2022 | -13.3% | +135.2 |
| Q2 FY2022 | Jun 30, 2022 | 7.2% | – |
| Q1 FY2020 | Mar 31, 2020 | -200.9% | – |
| Q2 FY2019 | Jun 30, 2019 | -20.3% | – |
| Q1 FY2019 | Mar 31, 2019 | -148.5% | – |
See a number that looks wrong?